Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tannu

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 5, 2009
Synthesis and therapeutic evaluation of pyridyl based novel mTOR inhibitorsVijaykumar Deore, Nilambari Yewalkar, Dimple Bhatia, et al.
British Journal of Pharmacology|August 26, 2010
Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptorsS A Tannu, L M Renzetti, N Tare, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 4, 2016
BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivoScott J Bultman, Darcy Wood Holley, Gustaaf G de Ridder, et al.
Molecular Cancer|December 4, 2014
P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancerVenkatasubbaiah A Venkatesha, Asavari Joshi, Magesh Venkataraman, et al.
The Lancet. Child & Adolescent Health|October 2, 2021
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry studySara Khan, Palma Solano-Paez, Tannu Suwal, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2012
Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemiaSmriti Khanna, Sandeep Burudkar, Komal Bajaj, et al.
NEJM Evidence|May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial FibrillationSatoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Circulation|June 27, 2024
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes TrialManasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, et al.
Journal of Medicinal Chemistry|October 8, 2013
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domainRobert F Kester, Andrew F Donnell, Yan Lou, et al.
Journal of Medicinal Chemistry|April 13, 2010
Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1Robert A Goodnow, Alexandra Hicks, Achyutharao Sidduri, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|May 5, 2009
Synthesis and therapeutic evaluation of pyridyl based novel mTOR inhibitorsVijaykumar Deore, Nilambari Yewalkar, Dimple Bhatia, et al.
British Journal of Pharmacology|August 26, 2010
Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptorsS A Tannu, L M Renzetti, N Tare, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 4, 2016
BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivoScott J Bultman, Darcy Wood Holley, Gustaaf G de Ridder, et al.
Molecular Cancer|December 4, 2014
P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancerVenkatasubbaiah A Venkatesha, Asavari Joshi, Magesh Venkataraman, et al.
The Lancet. Child & Adolescent Health|October 2, 2021
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry studySara Khan, Palma Solano-Paez, Tannu Suwal, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2012
Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemiaSmriti Khanna, Sandeep Burudkar, Komal Bajaj, et al.
NEJM Evidence|May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial FibrillationSatoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Circulation|June 27, 2024
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes TrialManasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, et al.
Journal of Medicinal Chemistry|October 8, 2013
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domainRobert F Kester, Andrew F Donnell, Yan Lou, et al.
Journal of Medicinal Chemistry|April 13, 2010
Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1Robert A Goodnow, Alexandra Hicks, Achyutharao Sidduri, et al.
Pageof 11